Barbara Ryan
Barbara Ryan
Barbara Ryan Colemanis a fictional character from the American CBS soap opera As the World Turns. In the early 1970s, Barbara was played by a succession of actresses, but the actress most associated with the role is Colleen Zenk, who played her since September 1, 1978. Better known as simply Barbara Ryan she is portrayed as a heroine who experienced many tragedies, mostly at the hands of her controlling ex-husband, the villainous James Stenbeck...
altogether cash certainty clearly company disregard generic given greater industry litigation settle translate tremendous unlikely
Pfizer clearly is a company with tremendous disregard for the generic drug industry and is not given to settling. But it is not altogether unlikely that Pfizer could settle its litigation. If Pfizer could translate some of its cash hoards into greater certainty on this litigation ... I think they would do that.
company earnings improve merger pursuing
The only way this company can improve their earnings is through pursuing a merger or by being acquired. It's not very innovative, but it's what they're going to have to do.
company heads left management problems roll vulnerable zero
We're left with a company with a litany of problems and a management that has zero credibility. I think some heads will roll and they will be very vulnerable to take-out.
aided company deliver despite earnings faced pressures top
Despite the pressures that Pfizer has faced and will face on the top line, the company will be able to deliver on their earnings target, in part aided by introduction of their new drugs.
clear company growth vehicle view
The only company which is a clear growth vehicle in our view is Schering-Plough.
benefits company flow focus improving investors late likely product
Investors and company managements will likely focus on the benefits of restructuring and the improving new product flow for late 2006.
company gone radical
The company has gone through a radical transformation,
based cost earnings expect recovery year
Bristol-Myers earnings will be down this year but then we expect to see a recovery based on the introduction of new drugs and cost cuts.
benefit lose money
Merck and Pfizer would probably lose money from a moratorium. They have portfolios that would benefit from DTC advertising.
benefit lose money
Merck and Pfizer would probably lose money from a moratorium, ... They have portfolios that would benefit from DTC advertising.
betting companies innovative pipeline worse
Lilly has been more innovative than most other companies but done worse at execution. There's betting on a pipeline that hasn't panned out in the past.
change higher people point
It doesn't change much. But it does point people to the higher end of the range.
fold months street telling tent three waiting wall
Three months ago, Wall Street was telling Pfizer to fold up its tent and go home. Now some of the things we've been waiting for are coming.
below brands generally key sales
Fourth-quarter 2005 sales of key brands were generally below our forecasts.